Skip to main content
. 2024 Jun 15;16(6):2697–2715. doi: 10.4251/wjgo.v16.i6.2697

Figure 2.

Figure 2

Indole-3-acetaldehyde inhibits proliferation of colorectal cancer cells in vitro. A and B: Growth curves of HCT116 and DLD-1 cells treated with IAAD; C and D: Vitality of HCT116 and DLD-1 cells treated with different concentrations of indole-3-acetaldehyde after 48 h, compared with the control group; E and F: The expression of Ki-67 in the nucleus was determined by immunofluorescence. aP < 0.05, 50 μmol/L indole-3-acetaldehyde treatment group vs control group; bP < 0.01, 50 μmol/L indole-3-acetaldehyde treatment group vs control group; dP < 0.01, 100 μmol/L indole-3-acetaldehyde treatment group vs control group. DAPI: 4’,6-diamidino-2-phenylindole.